Be Ready to Prescribe Alternatives to Valsartan
The valsartan recall will continue to raise questions about how to switch to a different ARB or an ACE inhibitor.
The generic products impacted are a moving target. For now, the recall also includes some combos with hydrochlorothiazide or amlodipine.
The recalled products may have been contaminated with the probable carcinogen N-nitrosodimethylamine (NDMA) for as long as 4 years...possibly because of changes in how valsartan was made.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote